CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
85 hedge funds and large institutions have $203M invested in Concert Pharmaceuticals, Inc. in 2022 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 28 increasing their positions, 24 reducing their positions, and 13 closing their positions.
Holders
85
Holders Change
+5
Holders Change %
+6.25%
% of All Funds
1.37%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
18
Increased
28
Reduced
24
Closed
13
Calls
$1.12M
Puts
$224K
Net Calls
+$898K
Net Calls Change
-$113K
Top Buyers
1 |
KCM
1
Kynam Capital Management
Princeton,
New Jersey
|
$25.8M |
2 |
2
Point72 Asset Management
Stamford,
Connecticut
|
$7.83M |
3 |
3
Bank of Montreal
Toronto,
Ontario, Canada
|
$3.19M |
4 |
4
BlackRock
New York
|
$7.22M |
5 |
5
Citadel Advisors
Miami,
Florida
|
$8.13M |